Instrument Inactif

Communiqués Diffusion Pharma

Actions

DFFN

US2537484048

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Diffusion Pharma : CervoMed Corporate Presentation December 2023	21/12	PU
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma	15/08/23	AQ
Diffusion Pharmaceuticals : EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies - Form 8-K	14/08/23	PU
Diffusion Pharmaceuticals : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	09/08/23	PU
Diffusion Pharmaceuticals : EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference - Form 8-K	03/08/23	PU
DIFFUSION PHARMACEUTICALS INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	21/06/23	AQ
DIFFUSION PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K)	15/05/23	AQ
Diffusion Pharmaceuticals : EIP Pharma to Present at JMP Securities Life Sciences Conference - Form 8-K	11/05/23	PU
DIFFUSION PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Diffusion Pharmaceuticals Inc. - DFFN	01/04/23	BU
DFFN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Diffusion Pharmaceuticals Inc. Is Fair to Shareholders	30/03/23	BU
DIFFUSION PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	30/03/23	AQ
Diffusion Pharmaceuticals : FORM OF PARENT STOCKHOLDER SUPPORT AGREEMENT - Form 8-K	30/03/23	PU
EIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company Treating Neurodegenerative Diseases	30/03/23	AQ
DIFFUSION PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	24/03/23	AQ
DIFFUSION PHARMACEUTICALS INC. : Termination of a Material Definitive Agreement, Costs Associated with Exit or Disposal Activities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	16/02/23	AQ
DIFFUSION PHARMACEUTICALS INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	30/12/22	AQ
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities	19/12/22	AQ
DIFFUSION PHARMACEUTICALS INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	16/12/22	AQ
Diffusion Pharmaceuticals Announces Agreement with LifeSci Special Opportunities	16/12/22	AQ
DIFFUSION PHARMACEUTICALS INC. : Other Events, Financial Statements and Exhibits (form 8-K)	06/12/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Diffusion Pharma

Actions

DFFN

US2537484048

Communiqués

Filtres